NIH to fund trial in Washington state; any vaccine still 12-18 months away
BREAKING: Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine. Follow AP coverage of the virus outbreak: https://t.co/nrwRgvP6bo
— The Associated Press (@AP) March 15, 2020
The trial will take place at a Kaiser Permanente research facility in Washington state.
It will take a year to 18 months to validate the vaccine.
The National Institutes of Health is funding the study.
The Associated Press contributed to this report.